James Howard Tonsgard to Clinical Trials as Topic
This is a "connection" page, showing publications James Howard Tonsgard has written about Clinical Trials as Topic.
Connection Strength
0.361
-
Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1. Ann Clin Transl Neurol. 2019 12; 6(12):2555-2565.
Score: 0.123
-
Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials. Neurology. 2016 Aug 16; 87(7 Suppl 1):S4-S12.
Score: 0.098
-
Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials. Neurology. 2013 Nov 19; 81(21 Suppl 1):S6-14.
Score: 0.081
-
Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2. Clin Cancer Res. 2009 Aug 15; 15(16):5032-5039.
Score: 0.060